BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

247 related articles for article (PubMed ID: 28240419)

  • 1. Enhanced Antimicrobial Effects of Decellularized Extracellular Matrix (CorMatrix) with Added Vancomycin and Gentamicin for Device Implant Protection.
    Deering TF; Chang C; Snyder C; Natarajan SK; Matheny R
    Pacing Clin Electrophysiol; 2017 Jun; 40(6):615-623. PubMed ID: 28240419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical evaluation of efficacy and pharmacokinetics of gentamicin containing extracellular-matrix envelope.
    Sohail MR; Esquer Garrigos Z; Elayi CS; Xiang K; Catanzaro JN
    Pacing Clin Electrophysiol; 2020 Mar; 43(3):341-349. PubMed ID: 32067241
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An off-the-shelf plasma-based material to prevent pacemaker pocket infection.
    Schwartzman D; Pasculle AW; Ceceris KD; Smith JD; Weiss LE; Campbell PG
    Biomaterials; 2015 Aug; 60():1-8. PubMed ID: 25965281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Staphylococcus aureus Prosthetic Joint Infection Is Prevented by a Fluorine- and Phosphorus-Doped Nanostructured Ti-6Al-4V Alloy Loaded With Gentamicin and Vancomycin.
    Auñón Á; Esteban J; Doadrio AL; Boiza-Sánchez M; Mediero A; Eguibar-Blázquez D; Cordero-Ampuero J; Conde A; Arenas MÁ; de-Damborenea JJ; Aguilera-Correa JJ
    J Orthop Res; 2020 Mar; 38(3):588-597. PubMed ID: 31608498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differences between cardiac implantable electronic device envelopes evaluated in an animal model.
    Ip JE; Xu L; Lerman BB
    J Cardiovasc Electrophysiol; 2021 May; 32(5):1346-1354. PubMed ID: 33010088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Infection control in implantation of cardiac implantable electronic devices: current evidence, controversial points, and unresolved issues.
    Korantzopoulos P; Sideris S; Dilaveris P; Gatzoulis K; Goudevenos JA
    Europace; 2016 Apr; 18(4):473-8. PubMed ID: 26516219
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of antibiotic envelopes to prevent cardiac implantable electronic device infections: A meta-analysis.
    Koerber SM; Turagam MK; Winterfield J; Gautam S; Gold MR
    J Cardiovasc Electrophysiol; 2018 Apr; 29(4):609-615. PubMed ID: 29364546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting risk of endovascular device infection in patients with Staphylococcus aureus bacteremia (PREDICT-SAB).
    Sohail MR; Palraj BR; Khalid S; Uslan DZ; Al-Saffar F; Friedman PA; Hayes DL; Lohse CM; Wilson WR; Steckelberg JM; Baddour LM
    Circ Arrhythm Electrophysiol; 2015 Feb; 8(1):137-44. PubMed ID: 25504648
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention of Arrhythmia Device Infection Trial: The PADIT Trial.
    Krahn AD; Longtin Y; Philippon F; Birnie DH; Manlucu J; Angaran P; Rinne C; Coutu B; Low RA; Essebag V; Morillo C; Redfearn D; Toal S; Becker G; Degrâce M; Thibault B; Crystal E; Tung S; LeMaitre J; Sultan O; Bennett M; Bashir J; Ayala-Paredes F; Gervais P; Rioux L; Hemels MEW; Bouwels LHR; van Vlies B; Wang J; Exner DV; Dorian P; Parkash R; Alings M; Connolly SJ
    J Am Coll Cardiol; 2018 Dec; 72(24):3098-3109. PubMed ID: 30545448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antibacterial Envelope to Prevent Cardiac Implantable Device Infection.
    Tarakji KG; Mittal S; Kennergren C; Corey R; Poole JE; Schloss E; Gallastegui J; Pickett RA; Evonich R; Philippon F; McComb JM; Roark SF; Sorrentino D; Sholevar D; Cronin E; Berman B; Riggio D; Biffi M; Khan H; Silver MT; Collier J; Eldadah Z; Wright DJ; Lande JD; Lexcen DR; Cheng A; Wilkoff BL;
    N Engl J Med; 2019 May; 380(20):1895-1905. PubMed ID: 30883056
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Contemporary management of cardiovascular implantable electronic device infections.
    Sohail MR; Sultan OW; Raza SS
    Expert Rev Anti Infect Ther; 2010 Jul; 8(7):831-9. PubMed ID: 20586567
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Retrospective comparative analysis of cardiovascular implantable electronic device infections with and without the use of antibacterial envelopes.
    Hassoun A; Thottacherry ED; Raja M; Scully M; Azarbal A
    J Hosp Infect; 2017 Mar; 95(3):286-291. PubMed ID: 28131641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CIED infection with either pocket or systemic infection presentation--complete device removal and long-term antibiotic treatment; long-term outcome.
    Ihlemann N; Møller-Hansen M; Salado-Rasmussen K; Videbæk R; Moser C; Iversen K; Bundgaard H
    Scand Cardiovasc J; 2016; 50(1):52-7. PubMed ID: 26485501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cardiac implantable electronic device infections: presentation, management, and patient outcomes.
    Tarakji KG; Chan EJ; Cantillon DJ; Doonan AL; Hu T; Schmitt S; Fraser TG; Kim A; Gordon SM; Wilkoff BL
    Heart Rhythm; 2010 Aug; 7(8):1043-7. PubMed ID: 20470904
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diagnosis and management of staphylococcal infections of pacemakers and cardiac defibrillators.
    Chambers ST
    Intern Med J; 2005 Dec; 35 Suppl 2():S63-71. PubMed ID: 16271062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcutaneous lead implantation connected to an externalized pacemaker in patients with implantable cardiac defibrillator/pacemaker infection and pacemaker dependency.
    Pecha S; Aydin MA; Yildirim Y; Sill B; Reiter B; Wilke I; Reichenspurner H; Treede H
    Europace; 2013 Aug; 15(8):1205-9. PubMed ID: 23426553
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiac Electrophysiology Laboratories: A Potential Target for Antimicrobial Stewardship and Quality Improvement?
    Branch-Elliman W; Stanislawski M; Strymish J; Barón AE; Gupta K; Varosy PD; Gold HS; Ho PM
    Infect Control Hosp Epidemiol; 2016 Sep; 37(9):1005-11. PubMed ID: 27322021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cardiovascular implantable electronic device associated infections.
    Gandhi T; Crawford T; Riddell J
    Infect Dis Clin North Am; 2012 Mar; 26(1):57-76. PubMed ID: 22284376
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Antibiotic-Eluting Envelopes to Prevent Cardiac-Implantable Electronic Device Infection: Past, Present, and Future.
    Xiang K; Catanzaro JN; Elayi C; Esquer Garrigos Z; Sohail MR
    Cureus; 2021 Feb; 13(2):e13088. PubMed ID: 33728111
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preoperative skin antiseptics for prevention of cardiac implantable electronic device infections: a historical-controlled interventional trial comparing aqueous against alcoholic povidone-iodine solutions.
    Da Costa A; Tulane C; Dauphinot V; Terreaux J; Romeyer-Bouchard C; Gate-Martinet A; Levallois M; Isaaz K
    Europace; 2015 Jul; 17(7):1092-8. PubMed ID: 25917024
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.